- Home
- FSP vs KRRO Comparison
FSP vs KRRO Comparison
Compare FSP & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- KRRO
- Stock Information
- Founded
- FSP 1981
- KRRO 2014
- Country
- FSP United States
- KRRO United States
- Employees
- FSP N/A
- KRRO N/A
- Industry
- FSP Real Estate Investment Trusts
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- FSP Real Estate
- KRRO Health Care
- Exchange
- FSP Nasdaq
- KRRO Nasdaq
- Market Cap
- FSP 166.9M
- KRRO 147.4M
- IPO Year
- FSP N/A
- KRRO 2019
- Fundamental
- Price
- FSP $1.68
- KRRO $30.76
- Analyst Decision
- FSP
- KRRO Strong Buy
- Analyst Count
- FSP 0
- KRRO 7
- Target Price
- FSP N/A
- KRRO $96.71
- AVG Volume (30 Days)
- FSP 307.8K
- KRRO 241.5K
- Earning Date
- FSP 10-28-2025
- KRRO 11-11-2025
- Dividend Yield
- FSP 2.38%
- KRRO N/A
- EPS Growth
- FSP N/A
- KRRO N/A
- EPS
- FSP N/A
- KRRO N/A
- Revenue
- FSP $111,879,000.00
- KRRO $6,281,000.00
- Revenue This Year
- FSP $4.36
- KRRO $97.27
- Revenue Next Year
- FSP $0.81
- KRRO N/A
- P/E Ratio
- FSP N/A
- KRRO N/A
- Revenue Growth
- FSP N/A
- KRRO N/A
- 52 Week Low
- FSP $1.36
- KRRO $10.29
- 52 Week High
- FSP $2.21
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- FSP 53.50
- KRRO 64.76
- Support Level
- FSP $1.64
- KRRO $20.20
- Resistance Level
- FSP $1.72
- KRRO $37.03
- Average True Range (ATR)
- FSP 0.06
- KRRO 3.59
- MACD
- FSP 0.00
- KRRO 0.79
- Stochastic Oscillator
- FSP 45.45
- KRRO 64.15
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.